Sign in

Private company

Galecto Biotech

Danish biotechnology company

Galecto Biotech is a biotechnology company that develops small molecules for the treatment of severe diseases, including fibrosis, cancer and inflammation. The company was founded in 2011 by leading galectin scientists and biotech executives from Sweden, United Kingdom, and Denmark.2 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

2011Founded1

See how the biggest companies compare on our leaderboards

Galecto Biotech is a biotechnology company that develops small molecules for the treatment of severe diseases, including fibrosis, cancer and inflammation. The company was founded in 2011 by leading galectin scientists and biotech executives from Sweden, United Kingdom, and Denmark.2

Corporate structure

Galecto Biotech is part of a group headed by Damora Therapeutics, Inc.. 5 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

  • Damora Therapeutics, Inc. Waltham, Massachusetts
    • Galecto Biotech Copenhagen
    • Damora Securities Corporation Subsidiary · Massachusetts, United States
    • Galecto Biotech ApS Subsidiary · Denmark
    • PharmAkea, Inc. Subsidiary · Delaware, United States

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

Timeline

  1. 2011Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2